Biotech Industry Examiner

Menu
Menu
subscribe now
Search
The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price

The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price

For the wealthy and the wellness-obsessed, the pursuit of longevity

Manulife and World Economic Forum Launch Longevity Innovation Challenge

Manulife and World Economic Forum Launch Longevity Innovation Challenge

Manulife and World Economic Forum Launch Longevity Innovation Challenge In

Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In

Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In

Debating the Future: Can Aging Be Halted or Reversed? Introduction

A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads

A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads

From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle

From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle

Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up

Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities

Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities

MOST POPULAR

News

AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results
Light-Based Microcapillary Monitoring Expands Precision in Biotechnology
Novo Holdings Leads $100 Million Series C Financing for Asceneuron

Funding

Aging Science

Impact of Space Travel on Immune Function and Potential Countermeasures
Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In
Epigenetic Stability Linked to Lifespan in Mammals, Research Show
New Study Highlights the Impact of Early-Life Tobacco Exposure on Accelerated Aging

Genomics

M&A & Partnerships

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development

Biotech Stocks

Psychology

Innovative Study on Addiction by Mount Sinai and Rockefeller University

Copyright © Industry Examiner 2025 . All rights reserved.

Industry Examiner LLC 166 Geary St. STE 1500 #2640, San Francisco, CA 94108

Facebook Twitter Linkedin Link
Scroll to Top